Assenagon Asset Management S.A. Surface Oncology, Inc. Transaction History

Assenagon Asset Management S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$1.42 - $3.15 $65,065 - $144,336	-45,821 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$2.65 - $5.08 $121,425 - $232,770	45,821 New	45,821 $135,000
Q2 2021 Jul 15, 2021	SELL	$6.45 - $9.09 $163,642 - $230,622	-25,371 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$7.25 - $13.82 $183,939 - $350,627	25,371 New	25,371 $198,000
Q4 2020 Feb 01, 2021	SELL	$6.87 - $10.48 $139,344 - $212,565	-20,283 Closed	0 $0
Q3 2020 Oct 07, 2020	BUY	$5.06 - $7.23 $17,816 - $25,456	3,521 Added 21.01%	20,283 $140,000
Q2 2020 Jul 21, 2020	BUY	$1.57 - $6.56 $26,316 - $109,958	16,762 New	16,762 $110,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.